Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer-study protocol of the OPTIMA study
评估基于伊立替康的结直肠癌全身治疗期间的潜在生物标志物——OPTIMA 研究的研究方案
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14500-6
Russ, E; Ziemons, J; Hillege, L E; van Kuijk, S M J; de Jong, E M; Elbers, C; Deenen, M J; Borghuis, L H; Böhm, T M M; Kristen, P; Valk, L C; van Hellemond, I E G; Vestjens, H; Dietvorst, A; Baars, A; Goosens, A N M; Vermeulen, L; Buffart, T E; de Vos-Geelen, J; Penders, J; Redinbo, M R; Iersel, L Valkenburg-van; Smidt, M L